med fusion
Mary Duenzl is a Quality Assurance Representative at med fusion since March 2022, with extensive experience in medical technology and flow cytometry. Previously, Mary served as a Medical Technologist - Flow Cytometry Specialist at ProPath from March 2019 to February 2022, where leukemia and lymphoma testing were provided. In an earlier role as Supervisor at Ameripath North Texas, Mary managed flow cytometry operations. Mary's background includes positions at MyLabDFW, Cook Children's Health Care System, Parkland Hospital, and Emory University Hospital, showcasing expertise in hematology, immunophenotyping, and laboratory management. Mary holds a Bachelor of Science degree in Medical Technology from Texas State University.
This person is not in any teams
med fusion
med fusion is a leader in advanced laboratory and clinical trials services providing full spectrum diagnostics across the continuum of care in Oncology, Women’s Health and Urology. Using cutting edge technology and bioinformatic solutions to better diagnose, identify and target specific disease characteristics, we offer responsible and actionable results. Our integrated approach translates to more effective and efficient patient care making precision medicine possible. Our clinical trials expertise supports healthcare providers and biopharmaceutical partners with a hypothesis-to-conclusion suite of services. Headquartered in Lewisville, Texas, med fusion offers its specialized services throughout the U.S. med fusion is CAP certified and is recognized as a Roche Molecular Center of Excellence (MCOE).